Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
3h
Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US ambassador to UN
Ex-aide urges Biden to quit
Concedes to Evans in CO
Ex-Rep. Grimm paralyzed
Backs Scott as Senate leader
China builds nuclear reactor?
Cruise ship rescues 4 people
Ella Jenkins dies at 100
24 more monkeys found
Veteran homelessness drops
Delaney wins US House seat
WI abortion ban hearing
Tops box office with $16.2M
TN murder suspect arrested
Shooting suspect arrested
Reds honor Pete Rose
Quincy Jones laid to rest
Wins 3rd NASCAR Cup title
Taking charge of US borders
UKR drones strike Moscow
CA forced labor ban rejected
Israel strikes Gaza, Lebanon
UN nuclear head to visit Iran
AZ rejects 'curing' extension
COP29 summit begins
FTX sues Binance
Haiti replaces prime minister
Ranger dies in wildfire
Schweikert wins reelection
Feedback